Aurinia Pharmaceuticals Inc
AUPHHealthcare|Biotechnology|Canada
$15.79
-0.81 (-4.88%)
DCF (FCF)
$1.77
Tangible Book
$4.31
Graham Number
$14.51
Upcoming Data Readouts (2)
Mar 2029
Est. completion
P1P2Myasthenia Gravis, Generalized
Study of Aritinercept in Patients With Generalized Myasthenia Gravis
NCT07596901n=81
Mar 2029
Est. completion
P4Lupus Nephritis
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
NCT07611214n=150